Impact of abiraterone acetate with and without prior docetaxel chemotherapy on the survival of patients with metastatic castration-resistant prostate cancer: a population-based study

Division of Urology (Rocha, Aprikian, Hu, Prévost, Dragomir), Department of Surgery, McGill University; Research Institute of the McGill University Health Centre (Rocha, Hu, Prévost, Dragomir); Division of Medical Oncology (Vanhuyse) and Division of Radiation Oncology (Cury), Department of Oncology, McGill University; McGill University Health Centre (Aprikian, Vanhuyse, Cury), Montréal, Que.

Division of Urology (Rocha, Aprikian, Hu, Prévost, Dragomir), Department of Surgery, McGill University; Research Institute of the McGill University Health Centre (Rocha, Hu, Prévost, Dragomir); Division of Medical Oncology (Vanhuyse) and Division of Radiation Oncology (Cury), Department of Oncology, McGill University; McGill University Health Centre (Aprikian, Vanhuyse, Cury), Montréal, Que.

Division of Urology (Rocha, Aprikian, Hu, Prévost, Dragomir), Department of Surgery, McGill University; Research Institute of the McGill University Health Centre (Rocha, Hu, Prévost, Dragomir); Division of Medical Oncology (Vanhuyse) and Division of Radiation Oncology (Cury), Department of Oncology, McGill University; McGill University Health Centre (Aprikian, Vanhuyse, Cury), Montréal, Que.

Division of Urology (Rocha, Aprikian, Hu, Prévost, Dragomir), Department of Surgery, McGill University; Research Institute of the McGill University Health Centre (Rocha, Hu, Prévost, Dragomir); Division of Medical Oncology (Vanhuyse) and Division of Radiation Oncology (Cury), Department of Oncology, McGill University; McGill University Health Centre (Aprikian, Vanhuyse, Cury), Montréal, Que.

Division of Urology (Rocha, Aprikian, Hu, Prévost, Dragomir), Department of Surgery, McGill University; Research Institute of the McGill University Health Centre (Rocha, Hu, Prévost, Dragomir); Division of Medical Oncology (Vanhuyse) and Division of Radiation Oncology (Cury), Department of Oncology, McGill University; McGill University Health Centre (Aprikian, Vanhuyse, Cury), Montréal, Que.

Division of Urology (Rocha, Aprikian, Hu, Prévost, Dragomir), Department of Surgery, McGill University; Research Institute of the McGill University Health Centre (Rocha, Hu, Prévost, Dragomir); Division of Medical Oncology (Vanhuyse) and Division of Radiation Oncology (Cury), Department of Oncology, McGill University; McGill University Health Centre (Aprikian, Vanhuyse, Cury), Montréal, Que.

Division of Urology (Rocha, Aprikian, Hu, Prévost, Dragomir), Department of Surgery, McGill University; Research Institute of the McGill University Health Centre (Rocha, Hu, Prévost, Dragomir); Division of Medical Oncology (Vanhuyse) and Division of Radiation Oncology (Cury), Department of Oncology, McGill University; McGill University Health Centre (Aprikian, Vanhuyse, Cury), Montréal, Que.